INR 5071.0
(-0.64%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 17.14 Billion | 8.57 Billion | -1.62 Billion | 682.1 Million | -955.4 Million | 652.35 Million |
Net Income | 19.36 Billion | 14.02 Billion | 7.49 Billion | 6.03 Billion | 7.26 Billion | 7.78 Billion |
Depreciation & Amortization | 831.3 Million | 755.8 Million | 745.1 Million | 710.8 Million | 711.4 Million | 643.26 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -1.44 Billion | 2.99 Billion | -3.34 Billion | -782.4 Million | -1.56 Billion | 818.67 Million |
Other non-cash items | -8.02 Billion | -9.2 Billion | -6.51 Billion | -5.28 Billion | -7.36 Billion | -8.59 Billion |
Investing Cash Flow | 3.88 Billion | 5.08 Billion | 3.26 Billion | 3.48 Billion | 4.53 Billion | 4.16 Billion |
Investments in PPE | -4.41 Billion | -1.35 Billion | -388 Million | -420.9 Million | -1.09 Billion | -1.75 Billion |
Acquisitions | 1.04 Billion | 266.3 Million | 12.7 Million | 11.9 Million | 89.8 Million | 60.45 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 7.25 Billion | 6.17 Billion | 3.63 Billion | 3.89 Billion | 5.54 Billion | 5.85 Billion |
Financing Cash Flow | -4.48 Billion | -2.17 Billion | -1.83 Billion | -1.59 Billion | -6.04 Billion | -1.25 Billion |
Debt repayment | - | - | - | - | - | - |
Dividends payments | -4.47 Billion | -2.16 Billion | -1.8 Billion | -1.55 Billion | -2.61 Billion | -1.2 Billion |
Common Stock Repurchased | - | - | - | - | -2.77 Billion | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -7.5 Million | -15.7 Million | -31 Million | -45.5 Million | -649 Million | -51.87 Million |
Accounts receivables | -8.59 Billion | 77.6 Million | -375.6 Million | 4.7 Billion | 461.1 Million | - |
Accounts payables | 244.4 Million | -18.01 Billion | -5.28 Billion | 11.06 Billion | 18.29 Billion | 4.67 Billion |
Inventory | 16.43 Billion | 3.43 Billion | -18.11 Billion | -12.65 Billion | -8.32 Billion | -43.34 Million |
Other working capital | -9.53 Billion | 17.5 Billion | 20.43 Billion | -3.89 Billion | -12 Billion | -3.81 Billion |
Cash at beginning of period | 18.68 Billion | 7.2 Billion | 7.39 Billion | 4.83 Billion | 7.29 Billion | 3.73 Billion |
Cash at end of period | 142.09 Billion | 18.68 Billion | 7.2 Billion | 7.39 Billion | 4.83 Billion | 7.29 Billion |
Capital Expenditure | -4.41 Billion | -1.35 Billion | -388 Million | -420.9 Million | -1.09 Billion | -1.75 Billion |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 123.41 Billion | 11.47 Billion | -194.4 Million | 2.56 Billion | -2.46 Billion | 3.56 Billion |
Free Cash Flow | 12.73 Billion | 7.22 Billion | -2.01 Billion | 261.2 Million | -2.05 Billion | -1.09 Billion |
Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 19.36 Billion | 6.26 Billion | 3.32 Billion | 3.14 Billion | 14.02 Billion | 3.26 Billion |
Depreciation & Amortization | 831.3 Million | 202.7 Million | 201.9 Million | 197.4 Million | 755.8 Million | 203.7 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -1.44 Billion | - | - | - | 2.99 Billion | - |
Other non-cash items | -8.02 Billion | -6.06 Billion | -201.9 Million | -197.4 Million | -9.2 Billion | -203.7 Million |
Investing Cash Flow | 3.88 Billion | - | - | - | 5.08 Billion | - |
Investments in PPE | -4.41 Billion | - | - | - | -1.35 Billion | - |
Acquisitions | 1.04 Billion | - | - | - | 266.3 Million | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 7.25 Billion | - | - | - | 6.17 Billion | - |
Financing Cash Flow | -4.48 Billion | - | - | - | -2.17 Billion | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | -4.47 Billion | - | - | - | -2.16 Billion | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | -15.7 Million | - |
Accounts receivables | -8.59 Billion | - | - | - | 77.6 Million | - |
Accounts payables | 244.4 Million | - | - | - | -18.01 Billion | - |
Inventory | 16.43 Billion | - | - | - | 3.43 Billion | - |
Other working capital | -9.53 Billion | - | - | - | 17.5 Billion | - |
Cash at beginning of period | 18.68 Billion | 138.01 Billion | 134.68 Billion | 18.68 Billion | 7.2 Billion | 15.42 Billion |
Cash at end of period | 142.09 Billion | 138.42 Billion | 138.01 Billion | 3.14 Billion | 18.68 Billion | 18.68 Billion |
Capital Expenditure | -4.41 Billion | - | - | - | -1.35 Billion | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 123.41 Billion | 405.4 Million | 3.32 Billion | -15.54 Billion | 11.47 Billion | 3.26 Billion |
Free Cash Flow | 12.73 Billion | 405.4 Million | 3.32 Billion | 3.14 Billion | 7.22 Billion | 3.26 Billion |
SURANASOL
MUKTAARTS
MAA
PSB
3252
ARGTF